Labor strikes are on the rise across the health care industry as workers feel overwhelmed by the demands of the Covid-19 era and increasingly concerned about pay and staffing shortages. And while "every strike is different,” according to Advisory Board's Carol Boston Fleischhauer, there are four "clear patterns" emerging as flash points in labor negotiations around the country.
This summer, the United Kingdom eased most pandemic restrictions, rolling back mask mandates and social distancing, once it achieved a high national vaccination rate. But as winter approaches, the U.K. is seeing Covid-19 case rates and hospitalizations rise again, suggesting that herd immunity to the coronavirus may be difficult to reach, Denise Roland reports for the Wall Street Journal.
A CDC advisory panel on Thursday unanimously voted to recommend booster shots for recipients of Moderna's and Johnson & Johnson's Covid-19 vaccines—but some committee members worried the recommendation could lead the "worried well" to get extra shots they don't need.
Biogen on Wednesday reported its new Alzheimer's drug, Aduhelm, fell short of its forecasted $12 million in sales for the drug's first full period of availability. For his part, Biogen CEO Michel Vounatsos said despite the lower-than-anticipated sales, the company still "believe[s] in Aduhelm's long-term potential." Advisory Board experts Nicholas Hula and Katie Schmalkuche dive into what Aduhelm’s performance actually says about current care infrastructure.
U.S. Surgeon General Vivek Murthy teamed up with Hinge to give tips on navigating dating and relationships during the pandemic, in today's bite-sized hospital and health industry news from Massachusetts, New Jersey, and New York.